High Blood Pressure & Cardiovascular Prevention

Why a New Hypertension Journal?: A Brief Response to the ‘Common Sense’ Question from Many Colleagues
pp. 1-2(2)
Author: Volpe M.

The ALLHAT Study: Non Evidence-Based Conclusions from Secondary Endpoints
pp. 3-6(4)
Author: Ambrosioni E.

Treatment of Hypertension: Is the Gap between Objectives and Outcomes Insurmountable?
pp. 7-9(3)
Author: Volpe M.

The Multicentre Atorvastatin Plaque Stabilisation (MAPS) Study: Proposed Rationale and Study Design
pp. 11-18(8)
Authors: Pauletto P.; Ferri C.; Volpe M.; Agabiti-Rosei E.; Maria Lorenza Muiesan; Puato M.; Faggin E.; Rattazzi M.; Plebani M.; Zambon A.; Desideri G.; Luca De Siati; Pierdomenico S.; Salvetti M.; Cipollone F.; Mezzetti A.

Is Endothelial Dysfunction a Measurable Endpoint in Hypertension?
pp. 19-25(7)
Authors: Taddei S.; Virdis A.; Ghiadoni L.; Versari D.; Salvetti A.

Oxidative Stress and Cardiovascular Disease
pp. 27-33(7)
Authors: Cosentino F.; Tocci G.; Francia P.; Schiavoni M.; Paola De Paolis; Gabriele Egidy Assenza; Maria Beatrice Musumeci

Monitoring Blood Pressure in Patients with Acute Stroke: Does it Have a Positive Value?
pp. 35-40(6)
Authors: Leonetti G.; Cuspidi C.; Stramba-Badiale M.; Zanchetti A.

New Frontiers in Cardiovascular Disease: Adrenomedullin
pp. 41-46(6)
Author: Savoia C.

Angiotensin Receptor Blockers: When Do We Prescribe Them in Patients with Diabetes Mellitus?
pp. 47-49(3)
Authors: Ruilope M.; Volpe M.

Hypertension in Postmenopausal Women as a Medical and Public Health Problem
pp. 51-55(5)
Authors: Scuteri A.; Fleg J.L.

Industry Pulse
pp. 57-63(7)